Society

Quality Management

Policy

Policy (our fundamental view)

We have established our Quality Policy in order to “provide the highest quality products and services” as stated in the Code of Conduct of the NOF Group Corporate Philosophy System, and strive to carry out sound quality management.

Quality Policy

The NOF Group provides the highest quality products and services that are based on our considerations of achieving harmony with society and customer satisfaction through our unrelenting quality management.
 

1. Harmony with society
We shall comply with laws, regulations, and rules, respect the environment, and produce safe and secure products using manufacturing processes that themselves are safe and secure.
 

2. Customer satisfaction practices
We shall listen to our customers’ requirements and provide products that meet expectations and useful information.
 

3. Unrelenting quality management
We shall maintain stable quality with continuous improvement and proper process management and enhance the management level through education.
 

4. Execution of quality assurance
We shall fulfil our commitment to our customers and sincerely respond to inquiries and complaints.

Organizational setup

In April 2019, NOF established the Quality Management Committee to supervise quality management and continue to secure the trust of society. The Committee is chaired by the General Manager of the Corporate Technical Division (concurrently Director and Executive Operating Officer) and has 9 other members (business division managers, related corporate division managers). Furthermore, in April 2023, the Quality Management Department was established in the Corporate Technical Division to maintain and improve the level of quality management across the entire Group by raising awareness of quality management and providing guidance on quality management systems (QMS*) operated by works, plants, and Group companies.
 

Acronym for Quality Management System. A system by which an organization formulates policies and sets targets in order to dictate and manage its quality, and achieve such targets.

Handling complaints and accidents related to products

In the event of consumer complaints regarding the function or quality of NOF products, or consumer accidents (product liability incidents) caused by, or assumed to have been caused by product defects, we organize a business division task force and respond in accordance with the direction of the RC Committee chair. In fiscal 2024, there were no product liability incidents.

QMS

Development status of QMS

NOF’s works and plants have acquired the most appropriate QMS certification for their business from competent outside bodies. The Functional Materials and Metal Coatings businesses are certified under ISO 9001, the Explosives & Propulsion business is certified under JIS Q 9100, and the Functional Foods business is certified under FSSC 22000 (Food Safety Management System). The Life Science business utilizes ICH-Q7 (Active Pharmaceutical Ingredients: GMP Guidelines). Fifteen Group companies have acquired certification by competent outside bodies, including ISO 9001 certification.
 

Rate of acquisition of QMS certification from competent outside bodies  (production volume basis)

  • FY2024[Covered organizations:Domestic Group]:98%
  • FY2024[Covered organizations:NOF Group]:97%

NOF
 

Works and plants Quality management systems Certification number Latest recertification date
Kawasaki Works Chidori Plant ISO 9001 JP026326 June 2025
Daishi Plant FSSC 22000
(Food Safety Management System)
JMAQA-FC270 January 2025
DDS Plant ICH-Q7
(Active Pharmaceutical Ingredients:
GMP Guidelines)
Aichi Works Taketoyo Plant JISQ 9100 JQA-AS0183 July 2022
Kinuura Plant ISO 9001 JP022549 June 2022
Amagasaki Plant (Functional
Materials Division)
ISO 9001 JP022753 August 2022
(Life Science Division) ICH-Q7
(Active Pharmaceutical Ingredients:
GMP Guidelines)
Oita Plant
 
ISO 9001 JP023986 September 2023

Group companies
 

Name Quality management systems Certification number Latest recertification date
Nippon Koki Co., Ltd. ISO 9001 JSAQ2282 September 2023
Nippon Koki Co., Ltd. Shirakawa Plant JISQ 9100 JQA-AS029 September 2023
NiGK Corporation ISO 9001 66885 March 2023
NOF METAL COATINGS ASIA PACIFIC
CO., LTD.
ISO 9001 JP023061 November 2022
Showa Kinzoku Kogyo Co., Ltd. ISO 9001 02479-2011-AQ-KOB-JAB March 2024
YUKA SANGYO CO., LTD. ISO 9001 19823082 April 2024
JEUNE BEAUTY CORPORATION, Amagasaki Factory ISO 22716
(cosmetics materials GMP)
JP024379 January 2024
JEUNE BEAUTY CORPORATION,
Chita Factory
ISO 22716
(cosmetics materials GMP)
JP024609 March 2024
Nichiyu Techno Co., Ltd. ISO 9001 JP024473 February 2024
NIKKA COATING CO., LTD. ISO 9001 3357 December 2024
Changshu NOF Chemical Co., Ltd. ISO 9001 CN20/21619 January 2024
PT.NOF MAS CHEMICAL INDUSTRIES ISO 9001 ID00/18019 April 2023
NOF METAL COATINGS
NORTH AMERICA INC.
ISO 9001 66561-IS8 July 2023
NOF METAL COATINGS EUROPE S.A. ISO 9001 BR040177 December 2023
NOF METAL COATINGS EUROPE N.V. ISO 9001 10477422 November 2022
NOF METAL COATINGS KOREA CO.,LTD. IATF 16949 RTS0250 November 2023
NOF METAL COATINGS SOUTH AMERICA IND. E COM.LTDA. ISO 9001 N°1994/2984.9 December 2023
NOF METAL COATINGS SHANGHAI
CO., LTD.
ISO 9001 016SH22Q33019R3S September 2023

Approach to Pharmaceutical-Related Products

NOF currently handles pharmaceutical-related products based on the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (“Pharmaceuticals and Medical Devices Act”), and has obtained the various business licenses listed below. In order to properly carry out these licensed business operations, the Pharmaceutical Management Task Force has been established under the Quality Management Committee to appropriately manage medical supplies.

Licensing status of pharmaceutical-related products
 

Category Works / plants
Marketing Second-class marketing license for pharmaceuticals NOF
Marketing license for quasi- pharmaceutical products NOF
Sales Wholesale pharmaceutical  sales NOF
Manufacturing Pharmaceutical  manufacturing Kawasaki Works
Aichi Works Taketoyo Plant
Amagasaki Plant

Basic Policy on Pharmaceutical-Related Products

Based on our corporate philosophy, which states, “the NOF Group is dedicated to contributing to humanity and society as a corporate group that creates new value through the power of chemistry, from the biosphere to outer space,” NOF is developing pharmaceutical-related business that ensures high quality, reliability, and safety for all stakeholders under our governance system that ensures thorough compliance with laws and regulations.

Pharmaceutical management system

Based on the aim of the Act Partially Amending the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (Act No. 63 of 2019, “Amended Pharmaceuticals and Medical Devices Act”), Officers with responsibility for pharmaceutical-related operations are clearly stated in the Pharmaceutical Management System. In addition, in accordance with the provisions of the same Act, for marketing (second-class marketing license for pharmaceuticals, marketing license for quasi-pharmaceutical products), a General Marketing Manager, Quality Assurance Manager, and Safety Management Manager have been appointed.
As a specialized task force of the Quality Management Committee, a deliberative body, NOF established the Pharmaceutical Management Task Force to oversee the pharmaceutical-related business of the entire Company and provide integrated management of manufacturing, marketing, and wholesale of pharmaceuticals. The Pharmaceutical Management Task Force inspects the status of compliance with GQP, GVP, and GMP ministerial ordinances and operates so as to ensure that the General Marketing Manager, manufacturing managers, and others provide appropriate opinions to responsible Officers regarding issues and problems related to legal compliance.

The responsible officer, the quality control committee, and the pharmaceutical affairs management subcommittee oversee the manufacturing and sales business, pharmaceutical manufacturing business, and pharmaceutical wholesale business.

Pharmaceutical management system diagram

Education and training

At NOF, all persons involved in pharmaceuticals take the required training every year.
 

Responsible Officers:Take the pharmaceuticals-related training (once per year)
People involved in pharmaceutical-related operations:Take training based on GQP, GVP, and GMP ministerial ordinances as needed
 

After the training, a record is made and stored for use in the next fiscal year’s training plan to ensure continued acquisition of the necessary knowledge.

Risks and Opportunities

Risks and opportunities in quality assurance
 

  • Quality targets:Zero serious complaints or inappropriate incidents
     
  • Key issue:Ensuring proper quality management at the NOF Group
     
Major risk Risk description Opportunities Major activities
Quality fraud
  • Loss of public trust and damage to corporate value due to quality problems such as falsification of quality inspection results
  • Continuous improvement of quality management throughout the Company and Group, and earning social trust through fair corporate activities

In 2023, we established a new code of conduct and issued a message from the President to implement specific actions in accordance with the corporate philosophy, which defines the mission and ideal state of the NOF Group, and the three values that are prioritized in implementing the corporate philosophy: Challenges, Fairness, and Harmony.
 

[Thoroughly ensuring proper quality management]

  • Development of a quality policy to “provide the highest quality products and services”
  • Raise awareness and educate employees through compliance manuals, etc.
  • Quality audits and periodic surveys
  • Thorough prevention of recurrence and horizontal development through reporting of quality anomalies (serious cases)
  • Promotion of automation of quality management and inspections (creation of a system that prevents fraud and falsification, etc.)
Quality defects and product problems
  • Loss of customer trust due to quality anomalies causing delivery delays to customers or quality anomalies in customer products
  • Gain customer trust through quality improvement and a proven track record

Contact